Winstrol (Stanozolol) is a synthetic anabolic steroid derived from dihydrotestosterone (DHT). Often praised for its ability to deliver dry gains, cut fat, and enhance vascularity without the bloating associated with other steroids, it is a go-to for bodybuilders looking to bring conditioning to the next level. This article delves into the uses and the often overlooked and misunderstood consequences of Winstrol use, especially when abused, run too long, or stacked poorly.
What is Winstrol?
Stanozolol, also known as Winstrol, is a synthetic steroid that has both anabolic and androgenic properties. It first came on the market in 1962. Over time, the marketing and labeling of stanozolol has been altered due to FDA requirements and changes in the drug market. It is currently classified as a Schedule III Controlled Substance in the United States and many other countries, meaning it is illegal to possess or use without a prescription. You can still find Winstrol on the black market or through underground labs, but these sources are often contaminated, underdosed, or misrepresented.
Forms and Administration
Stanozolol can be administered orally or intramuscularly. Each tablet for oral administration contains 2 mg of stanozolol.
Therapeutic Uses
Some of its therapeutic uses include the treatment of aplastic anemia and hereditary angioedema, although it is rarely used for these conditions because better treatment options exist. It has also been indicated as a treatment of various other medical conditions, such as vascular disorders, central precocious puberty, and growth failure. WINSTROL (anabolic steroids) is indicated prophylactically to decrease the frequency and severity of attacks of angioedema.
Dosage for Hereditary Angioedema
The dosage requirements for continuous treatment of hereditary angioedema with WINSTROL (anabolic steroids) should be individualized on the basis of the clinical response of the patient. It is recommended that the patient be started on 2 mg, three times a day. After a favorable initial response is obtained in terms of prevention of episodes of edematous attacks, the proper continuing dosage should be determined by decreasing the dosage at intervals of one to three months to a maintenance dosage of 2 mg a day. Some patients may be successfully managed on a 2 mg alternate day schedule. During the dose adjusting phase, close monitoring of the patient's response is indicated, particularly if the patient has a history of airway involvement.
Read also: Weight Loss Guide Andalusia, AL
Important Considerations
Attacks of hereditary angioedema are generally infrequent in childhood and the risks from stanozolol administration are substantially increased. Therefore, long-term prophylactic therapy with this drug is generally not recommended in children, and should only be undertaken with due consideration of the benefits and risks involved.
Common and Overlooked Side Effects
While most discussions focus on common side effects such as liver toxicity, joint pain, or HDL suppression, several overlooked and underreported consequences of Winstrol use warrant attention.
1. Collagen Degradation
One of the least discussed - yet most damaging - effects of Winstrol is its ability to degrade collagen synthesis. Winstrol has been shown to inhibit Type I collagen production while increasing Type III collagen - a weaker, less organized form. Type I collagen is critical for strong tendons, ligaments, and joint stability. This is one reason so many athletes suffer from pec tears, quad tendon ruptures, or chronic elbow/knee pain after a cycle - not from training error, but from a structurally compromised system. If you're cutting hard, dry, and lean - remember that your muscles might be ready, but your connective tissue may not be.
2. Neurochemical Agitation
While most users expect some level of irritability on cycle, Winstrol has a unique reputation for triggering a more intense, insidious kind of neurochemical agitation. Winstrol is a DHT-derived compound, and like other dihydrotestosterone-based steroids, it can influence neurotransmitter function by altering dopamine and serotonin receptor sensitivity, particularly in the limbic system - the emotional control center of the brain. These effects may feel manageable during the cycle, especially if masked by motivation or training focus - but they can ramp up post-cycle, especially if estrogen rebounds hard or serotonin drops. For some users, the neurological aftermath of Winstrol is harder to shake than the physical side effects - and far less talked about. CNS effects include habituation, excitation, insomnia, and depression.
3. Immune System Impairment
Winstrol is known to impair the activity of certain white blood cells, particularly lymphocytes and neutrophils, which play a central role in defending the body against pathogens. The result? This issue is amplified when Winstrol is stacked with other hepatotoxic compounds, or used during a deep caloric deficit. To offset this, users often need to bolster their immune system throughout the cycle with functional nutrition and targeted supplementation.
Read also: Beef jerky: A high-protein option for shedding pounds?
4. Vascular Stress
Winstrol’s dry, vascular appearance is one of the main reasons it's so appealing to bodybuilders, especially in the final weeks before a show or photoshoot. Winstrol significantly lowers estrogen levels due to its DHT-based structure and lack of aromatization. While this helps prevent water retention, it also strips away vascular elasticity, making capillaries more prone to rupture. Winstrol may make you look peeled, but your vascular system may be under silent stress.
5. Cardiometabolic Impact
It’s well known that Winstrol can tank HDL cholesterol and spike LDL - but most users underestimate just how rapidly and severely this shift occurs. These changes are not just short-term inconveniences. To mitigate these risks, proactive cardiovascular support isn’t optional - it’s mandatory. Winstrol may not aromatize, but its cardiometabolic impact is anything but mild. Blood lipid changes that are known to be associated with increased risk of atherosclerosis are seen in patients treated with androgens and anabolic steroids.
6. Hair Loss
Hair loss is often mentioned as a possibility on Winstrol, but rarely with the seriousness it deserves. This is not limited to older users or those with visible hair thinning.
7. Hormonal Suppression
Winstrol doesn’t convert to estrogen, and it doesn’t directly suppress testosterone as heavily as something like Deca or Tren. What makes Winstrol particularly tricky is that users often underestimate its suppressive effects, especially if they’re not running it with testosterone. Hormonal damage doesn’t always announce itself with big symptoms. During exogenous administration of anabolic steroids, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). Large doses of exogenous anabolic steroids may suppress spermatogenesis through inhibition of pituitary follicle stimulating hormone (FSH).
Additional Side Effects
The use of anabolic steroids such as Winstrol may be associated with serious adverse reactions, many of which are dose related. Patients should be placed on the lowest possible effective dose.
Read also: Inspiring Health Transformation
Hepatic Effects
Cholestatic jaundice with, rarely, hepatic necrosis and death. Hepatocellular neoplasms and peliosis hepatis have been reported in association with long-term androgenic-anabolic steroid therapy. Reversible changes in liver function tests also occur including increased bromsulphalein (BSP) retention and increases in serum bilirubin, glutamic oxaloacetic transaminase (SGOT), and alkaline phosphatase.
Genitourinary System
In men:
- Prepubertal: Phallic enlargement and increased frequency of erections.
- Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis and bladder irritability.
In women: Clitoral enlargement, menstrual irregularities.
In both sexes: Increased or decreased libido.
Gastrointestinal
Nausea, vomiting, diarrhea.
Hematologic
Bleeding in patients on concomitant anticoagulant therapy. Anabolic steroids may cause suppression of clotting factors II, V, VII, and X, and an increase in prothrombin time.
Breast
Gynecomastia.
Larynx
Deepening of the voice in women.
Hair
Hirsutism and male pattern baldness in women.
Skin
Acne (especially in women and prepubertal boys).
Skeletal
Premature closure of epiphyses in children.
Fluid and Electrolytes
Edema, retention of serum electrolytes (sodium, chloride, potassium, phosphate, calcium).
Metabolic/Endocrine
Decreased glucose tolerance, increased serum levels of low-density lipoproteins and decreased levels of high-density lipoproteins, increased creatine and creatinine excretion, increased serum levels of creatinine phosphokinase (CPK). The insulin or oral hypoglycemic dosage may need adjustment in diabetic patients who receive anabolic steroids.
Virilization
Some virilizing changes in women are irreversible even after prompt discontinuance of therapy and are not prevented by concomitant use of estrogens. Women should be observed for signs of virilization (deepening of the voice, hirsutism, acne, and clitoromegaly).
Cardiovascular Adverse Events
Cardiovascular effects may be precipitated in patients adversely affected by fluid retention.
Contraindications
- Male patients with carcinoma of the breast, or with known or suspected carcinoma of the prostate.
- Carcinoma of the breast in females with hypercalcemia; androgenic anabolic steroids may stimulate osteolytic resorption of bone.
- Nephrosis or the nephrotic phase of nephritis.
- WINSTROL (anabolic steroids) can cause fetal harm when administered to a pregnant woman. WINSTROL (anabolic steroids) is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.
Interactions
Anabolic steroids may increase sensitivity to anticoagulants; therefore, dosage of an anticoagulant may have to be decreased in order to maintain the prothrombin time at the desired therapeutic level.
Warnings
Peliosis Hepatis and Hepatic Neoplasms
PELIOSIS HEPATIS, A CONDITION IN WHICH LIVER AND SOMETIMES SPLENIC TISSUE IS REPLACED WITH BLOOD-FILLED CYSTS, HAS BEEN REPORTED IN PATIENTS RECEIVING ANDROGENIC ANABOLIC STEROID THERAPY. THESE CYSTS ARE SOMETIMES PRESENT WITH MINIMAL HEPATIC DYSFUNCTION, BUT AT OTHER TIMES THEY HAVE BEEN ASSOCIATED WITH LIVER FAILURE. THEY ARE OFTEN NOT RECOGNIZED UNTIL LIFE-THREATENING LIVER FAILURE OR INTRA-ABDOMINAL HEMORRHAGE DEVELOPS. WITHDRAWAL OF DRUG USUALLY RESULTS IN COMPLETE DISAPPEARANCE OF LESIONS. LIVER CELL TUMORS ARE ALSO REPORTED. MOST OFTEN THESE TUMORS ARE BENIGN AND ANDROGEN-DEPENDENT, BUT FATAL MALIGNANT TUMORS HAVE BEEN REPORTED. WITHDRAWAL OF DRUG OFTEN RESULTS IN REGRESSION OR CESSATION OF PROGRESSION OF THE TUMOR. HOWEVER, HEPATIC TUMORS ASSOCIATED WITH ANDROGENS OR ANABOLIC STEROIDS ARE MUCH MORE VASCULAR THAN OTHER HEPATIC TUMORS AND MAY BE SILENT UNTIL LIFE-THREATENING INTRA-ABDOMINAL HEMORRHAGE DEVELOPS.
Cardiovascular Risks
BLOOD LIPID CHANGES THAT ARE KNOWN TO BE ASSOCIATED WITH INCREASED RISK OF ATHEROSCLEROSIS ARE SEEN IN PATIENTS TREATED WITH ANDROGENS AND ANABOLIC STEROIDS. THESE CHANGES INCLUDE DECREASED HIGH-DENSITY LIPOPROTEIN AND SOMETIMES INCREASED LOW-DENSITY LIPOPROTEIN. THE CHANGES MAY BE VERY MARKED AND COULD HAVE A SERIOUS IMPACT ON THE RISK OF ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE.
Liver Dysfunction
Cholestatic hepatitis and jaundice occur with 17-alpha-alkylated androgens at relatively low doses. If cholestatic hepatitis with jaundice appears, the anabolic steroid should be discontinued. If liver function tests become abnormal, the patient should be monitored closely and the etiology determined. Generally, the anabolic steroid should be discontinued although in cases of mild abnormalities, the physician may elect to follow the patient carefully at a reduced drug dosage.
Hypercalcemia
In patients with breast cancer, anabolic steroid therapy may cause hypercalcemia by stimulating osteolysis. In this case, the drug should be discontinued.
Edema
Edema with or without congestive heart failure may be a serious complication in patients with preexisting cardiac, renal, or hepatic disease. Concomitant administration of adrenal cortical steroids or ACTH may add to the edema.
Prostatic Hypertrophy and Carcinoma
Geriatric male patients treated with androgenic anabolic steroids may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma.
Pediatric Use
In children, anabolic steroid treatment may accelerate bone maturation without producing compensatory gain in linear growth. This adverse effect may result in compromised adult stature. The younger the child, the greater the risk of compromising final mature height. The effect on bone maturation should be monitored by assessing bone age of the wrist and hand every six months.
Athletic Ability
Anabolic steroids have not been shown to enhance athletic ability.
Illegality and Risks of Black Market Products
Stanozolol (Winstrol) is a Schedule III controlled substance in the United States and many other countries, meaning it is illegal to possess or use without a prescription. You can still find Winstrol on the black market or through underground labs, but these sources are often contaminated, underdosed, or misrepresented.
Legal Alternatives and Natural Support Strategies
If you're serious about performance and physique goals, legal alternatives and natural support strategies - including structured nutrition, supplementation, and hormone-optimizing habits - offer safer, long-term pathways.